Founded Date: 2006
Last Funding Type: Venture - Series Unknown
Headquarters: Abingdon, Oxfordshire, United Kingdom
Investors Number: 7
Technology: Cancer
Employee Number: 51-100
Industry: Gene Therapy
Estimated Revenue: $10M to $50M
Number Of Exists: Venture - Series Unknown
Funding Status: N/A
Investor Type: Company
Investment Stage: N/A
Total Funding: $102.5M